C1QL1 and obesity due to melanocortin 4 receptor deficiency: Interestingly, a genome-wide association study implicated C1QL1 as a candidate gene associated with total body fat mass [24], indicating that C1QL1 is a potential new therapy for the aetiology of osteoporosis and obesity.